These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38390)

  • 1. Mechanism of phenothiazine inhibition of Ca2+-dependent guanosine 3',5'-(cyclic) monophosphate phosphodiesterase of brain.
    Filburn CR; Colpo FT; Sacktor B
    Mol Pharmacol; 1979 Mar; 15(2):257-62. PubMed ID: 38390
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds.
    Picq M; Dubois M; Prigent AF; Némoz G; Pacheco H
    Biochem Int; 1989 Jan; 18(1):47-57. PubMed ID: 2541724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ca2+-dependent regulation of cGMP-stimulated phosphodiesterase from the soluble fraction of the human brain].
    Medvedeva MV; Bobruskin ID
    Biokhimiia; 1994 Jun; 59(6):866-72. PubMed ID: 8075251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead- and calcium-mediated inhibition of bovine rod cGMP phosphodiesterase: interactions with magnesium.
    Srivastava D; Hurwitz RL; Fox DA
    Toxicol Appl Pharmacol; 1995 Sep; 134(1):43-52. PubMed ID: 7676457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput assay for cyclic nucleotide phosphodiesterases.
    Schilling RJ; Morgan DR; Kilpatrick BF
    Anal Biochem; 1994 Jan; 216(1):154-8. PubMed ID: 8135346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic GMP and phosphodiesterase 5 inhibitor therapies: what's on the horizon?
    Lincoln TM
    Mol Pharmacol; 2004 Jul; 66(1):11-3. PubMed ID: 15213291
    [No Abstract]   [Full Text] [Related]  

  • 8. Purification of calmodulin from bovine parotid gland.
    Yokoyama N; Murota Y; Saito M; Kon S; Furuyama S
    Biochem Int; 1983 Feb; 6(2):257-65. PubMed ID: 6089807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic GMP metabolism and its role in brain physiology.
    Domek-Łopacińska K; Strosznajder JB
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():15-34. PubMed ID: 16077188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
    Haynes J; Killilea DW; Peterson PD; Thompson WJ
    J Pharmacol Exp Ther; 1996 Feb; 276(2):752-7. PubMed ID: 8632346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the soluble fraction of the human brain: Kinetic properties and the effect of the antidepressant pyrazidol and its nitro analog on the enzyme].
    Medvedeva MV; Belov AA; Kireeva NN; Bobruskin ID
    Biokhimiia; 1993 May; 58(5):798-808. PubMed ID: 8393348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
    Tkachuk VA; Lazarevich VG; Men'shikov MIu; Severin SE
    Biokhimiia; 1978 Sep; 43(9):1622-30. PubMed ID: 214170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents.
    Weiss B; Levin RM
    Adv Cyclic Nucleotide Res; 1978; 9():285-303. PubMed ID: 27079
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.
    Wilkins MR; Settle SL; Needleman P
    J Clin Invest; 1990 Apr; 85(4):1274-9. PubMed ID: 2156897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
    Zhang L; Zhang Z; Zhang RL; Cui Y; LaPointe MC; Silver B; Chopp M
    Brain Res; 2006 Nov; 1118(1):192-8. PubMed ID: 16959227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two forms of cyclic nucleotide phosphodiesterase and Ca-dependent protein regulator from rabbit skeletal muscles].
    Lazarevich VG; Men'shikov MIu; Tkachuk VA
    Biokhimiia; 1979 Oct; 44(10):1842-51. PubMed ID: 228768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors.
    Sugita M; Black KL
    Cancer Res; 1998 Mar; 58(5):914-20. PubMed ID: 9500450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
    Levin RM; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metofenazate as a more selective calmodulin inhibitor than trifluoperazine.
    Tkachuk VA; Baldenkov GN; Feoktistov IA; Men'shikov MY; Quast U; Herzig JW
    Arzneimittelforschung; 1987 Sep; 37(9):1013-7. PubMed ID: 2449225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.